Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
ImmPACT Bio to Participate at the 2024 Cell and Gene Meeting on the Med Conference | ||
By: PR Newswire Association LLC. - 26 Mar 2024 | Back to overview list |
|
LOS ANGELES, March 26, 2024 /PRNewswire/ -- ImmPACT Bio USA, Inc. ("ImmPACT Bio"), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR) T-cell therapies for treating cancer and autoimmune diseases, today announced that it will participate at the 2024 Cell and Gene Meeting on the Med, to be held from April 9-11, 2024 in Rome, Italy. Sumant Ramachandra, M.D., Ph.D., ImmPACT Bio's chief executive officer, will provide a company presentation on Tuesday, April 9, 2024 at 12:00 PM CET. Dr. Ramachandra will also participate in an individual presentation and panel discussion entitled, "Advances in Targeting Autoimmune Disease," on Wednesday, April 10, 2024 at 10:45 AM CET. Virtual attendance is available which includes a livestream of ImmPACT Bio's presentation and the ability to view all conference sessions on-demand. Please visit https://meetingonthemed.com/ for full information including registration. About ImmPACT Bio View original content to download multimedia:https://www.prnewswire.com/news-releases/immpact-bio-to-participate-at-the-2024-cell-and-gene-meeting-on-the-med-conference-302098576.html SOURCE ImmPACT Bio USA Inc. |
||
|
||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |